These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 14585222)

  • 1. A modified SCID mouse model of HIV infection with utility for testing anti-HIV therapies.
    Pincus SH; Fang H; Wilkinson RA; Olson WC; Marcotte TK
    AIDS Res Hum Retroviruses; 2003 Oct; 19(10):901-8. PubMed ID: 14585222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection.
    Pincus SH; Fang H; Wilkinson RA; Marcotte TK; Robinson JE; Olson WC
    J Immunol; 2003 Feb; 170(4):2236-41. PubMed ID: 12574398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
    Miura Y; Misawa N; Maeda N; Inagaki Y; Tanaka Y; Ito M; Kayagaki N; Yamamoto N; Yagita H; Mizusawa H; Koyanagi Y
    J Exp Med; 2001 Mar; 193(5):651-60. PubMed ID: 11238596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates.
    Gauduin MC; Allaway GP; Olson WC; Weir R; Maddon PJ; Koup RA
    J Virol; 1998 Apr; 72(4):3475-8. PubMed ID: 9525686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults.
    Jacobson JM; Lowy I; Fletcher CV; O'Neill TJ; Tran DN; Ketas TJ; Trkola A; Klotman ME; Maddon PJ; Olson WC; Israel RJ
    J Infect Dis; 2000 Jul; 182(1):326-9. PubMed ID: 10882617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.
    Touraine JL; Sanhadji K; Sembeil R
    Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice.
    Sanhadji K; Grave L; Touraine JL; Leissner P; Rouzioux C; Firouzi R; Kehrli L; Tardy JC; Mehtali M
    AIDS; 2000 Dec; 14(18):2813-22. PubMed ID: 11153662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients.
    Steyaert S; Heyndrickx L; Verhoye L; Vermoesen T; Donners H; Fransen K; Van Wanzeele F; Vandergucht B; Vanham G; Leroux-Roels G; Vanlandschoot P
    Antiviral Res; 2007 Aug; 75(2):129-38. PubMed ID: 17379323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies.
    Lapenta C; Fais S; Rizza P; Spada M; Logozzi MA; Parlato S; Santini SM; Pirillo M; Belardelli F; Proietti E
    Antiviral Res; 1997 Nov; 36(2):81-90. PubMed ID: 9443664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
    Taggart BR; Harrington P; Hollingshead M
    Antiviral Res; 2004 Jul; 63(1):1-6. PubMed ID: 15196814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo testing of anti-HIV immunotoxins.
    Pincus SH; Marcotte TK; Forsyth BM; Fang H
    Methods Mol Biol; 2001; 166():277-94. PubMed ID: 11217373
    [No Abstract]   [Full Text] [Related]  

  • 14. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
    Koup RA; Safrit JT; Weir R; Gauduin MC
    Semin Immunol; 1996 Aug; 8(4):263-8. PubMed ID: 8883150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis.
    Thomas T; Seay K; Zheng JH; Zhang C; Ochsenbauer C; Kappes JC; Goldstein H
    Methods Mol Biol; 2016; 1354():221-35. PubMed ID: 26714715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection.
    Alder J; Hui YH; Clement J
    Antiviral Res; 1995 May; 27(1-2):85-97. PubMed ID: 7486961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1
    Ogata-Aoki H; Higashi-Kuwata N; Hattori SI; Hayashi H; Danish M; Aoki M; Shiotsu C; Hashiguchi Y; Hamada A; Kobayashi H; Ihn H; Okada S; Mitsuya H
    Antiviral Res; 2018 Jan; 149():78-88. PubMed ID: 28893602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study Team.
    Shearer WT; Israel RJ; Starr S; Fletcher CV; Wara D; Rathore M; Church J; DeVille J; Fenton T; Graham B; Samson P; Staprans S; McNamara J; Moye J; Maddon PJ; Olson WC
    J Infect Dis; 2000 Dec; 182(6):1774-9. PubMed ID: 11069253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection.
    Miura Y; Misawa N; Kawano Y; Okada H; Inagaki Y; Yamamoto N; Ito M; Yagita H; Okumura K; Mizusawa H; Koyanagi Y
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2777-82. PubMed ID: 12601160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.